An open-label study of the therapeutic efficacy of high-dose famotidine adjuvant pharmacotherapy in schizophrenia: preliminary evidence for treatment efficacy.

Saved in:
Bibliographic Details
Title: An open-label study of the therapeutic efficacy of high-dose famotidine adjuvant pharmacotherapy in schizophrenia: preliminary evidence for treatment efficacy.
Authors: Rosse RB; Psychiatry Service, Department of Veterans Affairs Medical Center, Washington, DC 20422, USA., Kendrick K, Fay-McCarthy M, Prell GD, Rosenberg P, Tsui LC, Wyatt RJ, Deutsch SI
Source: Clinical neuropharmacology [Clin Neuropharmacol] 1996 Aug; Vol. 19 (4), pp. 341-8.
Publication Type: Clinical Trial; Journal Article
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 7607910 Publication Model: Print Cited Medium: Print ISSN: 0362-5664 (Print) Linking ISSN: 03625664 NLM ISO Abbreviation: Clin Neuropharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0362-5664
DOI:10.1097/00002826-199619040-00007